AU5092493A - Sustained release of ophthalmic drugs from a soluble polymer drug delivery vehicle - Google Patents

Sustained release of ophthalmic drugs from a soluble polymer drug delivery vehicle

Info

Publication number
AU5092493A
AU5092493A AU50924/93A AU5092493A AU5092493A AU 5092493 A AU5092493 A AU 5092493A AU 50924/93 A AU50924/93 A AU 50924/93A AU 5092493 A AU5092493 A AU 5092493A AU 5092493 A AU5092493 A AU 5092493A
Authority
AU
Australia
Prior art keywords
drug delivery
sustained release
soluble polymer
delivery vehicle
polymer drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU50924/93A
Inventor
Anne Lebesby Hoeg
David Louis Meadows
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Allergan Inc
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of AU5092493A publication Critical patent/AU5092493A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts, ocular implants

Landscapes

  • Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
AU50924/93A 1992-09-08 1993-08-27 Sustained release of ophthalmic drugs from a soluble polymer drug delivery vehicle Abandoned AU5092493A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US94139092A 1992-09-08 1992-09-08
US941390 1992-09-08
PCT/US1993/008020 WO1994005257A1 (en) 1992-09-08 1993-08-27 Sustained release of ophthalmic drugs from a soluble polymer drug delivery vehicle

Publications (1)

Publication Number Publication Date
AU5092493A true AU5092493A (en) 1994-03-29

Family

ID=25476396

Family Applications (1)

Application Number Title Priority Date Filing Date
AU50924/93A Abandoned AU5092493A (en) 1992-09-08 1993-08-27 Sustained release of ophthalmic drugs from a soluble polymer drug delivery vehicle

Country Status (2)

Country Link
AU (1) AU5092493A (en)
WO (1) WO1994005257A1 (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19756314C2 (en) * 1997-12-12 2000-06-29 Roland Bodmeier Preparation with extended residence time at the application site
JP4549529B2 (en) * 1998-01-30 2010-09-22 サイオス，インコーポレーテッド Controlled release delivery of peptides or proteins
GB2344519B (en) * 1998-12-07 2004-05-19 Johnson & Johnson Medical Ltd Sterile therapeutic compositions
US6416777B1 (en) 1999-10-21 2002-07-09 Alcon Universal Ltd. Ophthalmic drug delivery device
PT1221917E (en) 1999-10-21 2005-04-29 Alcon Inc DEVICE FOR MINISTRY OF MEDICINES
EP1522289A3 (en) 1999-10-21 2008-01-23 Alcon, Inc Sub-tenon drug delivery
US7943162B2 (en) 1999-10-21 2011-05-17 Alcon, Inc. Drug delivery device
DE10133870A1 (en) * 2001-07-12 2003-02-06 Chris P Lohmann Ophthalmic agent, use of EGF for the treatment of dry eye syndrome and insert for the administration of EGF to the eye
WO2003009774A2 (en) 2001-07-23 2003-02-06 Alcon, Inc. Ophthalmic drug delivery device
EP1385452B1 (en) 2001-07-23 2006-09-13 Alcon, Inc. Ophthalmic drug delivery device
FR2833493B1 (en) * 2001-12-18 2005-09-23 Ioltechnologie Production SOLID AND SOLUBLE GALENIC FORM FOR OCCULAR ADMINISTRATION OF ACTIVE INGREDIENTS AND PROCESS FOR PRODUCING A SOLID AND SOLUBLE OPHTHALMIC INSERT
CN100355455C (en) 2002-07-15 2007-12-19 爱尔康公司 Non-polymeric lipophilic pharmaceutical implant compositions for intraocular use
US7976520B2 (en) 2004-01-12 2011-07-12 Nulens Ltd. Eye wall anchored fixtures
AU2006213673A1 (en) 2005-02-09 2006-08-17 Santen Pharmaceutical Co., Ltd. Formulations for ocular treatment
US9804295B2 (en) * 2005-05-05 2017-10-31 Novartis Ag Ophthalmic devices for sustained delivery of active compounds
WO2007085024A2 (en) * 2006-01-21 2007-07-26 Abbott Gmbh & Co. Kg Dosage form and method for the delivery of drugs of abuse
CA2635797C (en) 2006-02-09 2015-03-31 Macusight, Inc. Stable formulations, and methods of their preparation and use
JP5506378B2 (en) 2006-03-23 2014-05-28 参天製薬株式会社 Formulations and methods for diseases or conditions associated with vascular permeability
US9226907B2 (en) 2008-02-01 2016-01-05 Abbvie Inc. Extended release hydrocodone acetaminophen and related methods and uses thereof
US8372036B2 (en) 2009-05-06 2013-02-12 Alcon Research, Ltd. Multi-layer heat assembly for a drug delivery device
US8177747B2 (en) 2009-12-22 2012-05-15 Alcon Research, Ltd. Method and apparatus for drug delivery
WO2014184243A1 (en) 2013-05-16 2014-11-20 Universiteit Antwerpen Thermolabile drug release formulation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT75625B (en) * 1981-10-08 1985-12-09 Merck & Co Inc Process for preparing biosoluble ocular insert
JPS6471822A (en) * 1987-09-12 1989-03-16 Rohto Pharma Ophthalmic sustained release preparation

Also Published As

Publication number Publication date
WO1994005257A1 (en) 1994-03-17

Similar Documents

Publication Publication Date Title
AU5092493A (en) Sustained release of ophthalmic drugs from a soluble polymer drug delivery vehicle
AU4111093A (en) Subconjunctival implants for ocular drug delivery
AU8781798A (en) Sustained release drug delivery system suitable for oral administration
AU5263496A (en) Targeted catheter drug administration
AU4989993A (en) Drug delivery system
AU9224498A (en) Matrix for controlled delivery of highly soluble drugs
AU664807B2 (en) Drug delivery system
AU4406793A (en) Water-soluble polymeric carriers for drug delivery
AU1025297A (en) A controlled release formulation for poorly soluble basic drugs
AU5533196A (en) Infusor system for delivery of medication to a body cavity
AU6534894A (en) Drug administration system
AU6957596A (en) Implantable drug delivery apparatus
AU5945296A (en) Medicament for nasal administration
IL180450A0 (en) Pharmaceutical formulations comprising a waterinsoluble complex for sustained drug delivery
AU7676894A (en) Convection-enhanced drug delivery
AU6847796A (en) Medication dispensing intra-ocular lens system
AU632539B2 (en) Pharmaceutical compositions useful as drug delivery vehicles and/or as wound dressings
EP0897708A3 (en) Drug delivery container having a luer filter
AU8933391A (en) Medical drug formulation and delivery system
AU7668894A (en) Hydrogel-based microsphere drug delivery systems
AU2827095A (en) Controlled release oral drug delivery system
AU6853596A (en) Transdermal drug delivery device having enhanced adhesion
AU1535799A (en) Pharmaceutical hydrogel formulations, drug delivery devices and methods
HUP0001914A3 (en) Biocompatible compounds for pharmaceutical drug delivery systems
NZ331904A (en) Transdermal patch for administration of drugs through a controlled and sustained release system